SELECTED PATENTS
(1) “Processes for preparing 5,7-diamino pyrazolo[1,5-.alpha.]pyrimidine derivatives via regioselective aminations of dichloro(pyrazolo)pyrimidines with primary and secondary
amines” Liotta, D. C.; Synder, J. P.; Jogalekar, A. S.; Barrett, A. G. M.; Fuchter, M. J.; Cook, M.; Kroll, S. H. B. 2010, WO2010068838
(2) “Quinazoline compounds and their use in therapy” Brown, R.; Fuchter, M. J.; Chapman-Rothe, N.; Srimongkolpithak, N.; Caron, J.; Snyder, J.; Ganesh, T.; Liu, J.; Sun, A. 2013, WO2013140148
(3) “Electroluminescent compositions” Yang, Y.; Campbell, A. J.; Fuchter, M. J. 2014, WO2014016611
(4) “Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use” Bondke, A.; Kroll, S.; Barrett, A. G. M.; Fuchter, M. J.; Slafer, B.; Ali, S.; Coombes, R. C.; Synder J. 2015, WO2015124941
(5) Fuchter, M. J.; Brady, H. 2018, WO2018/158587
(6) Fuchter, M. J.; Brady, H. 2018, WO2018/178666
(7) Fuchter, M. J.; Brady, H. 2020, WO2020/002911
See also: